Dr Nick Scott, Ms Anna Palmer, Mr Tom Tidhar, Prof Mark Stoove, Dr Rachel Sacks-Davis, A/Prof Joseph S. Doyle, . . . Prof Margaret Hellard. (2022). Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: A modelling study. Elsevier.
Chicago Style (17th ed.) CitationDr Nick Scott, et al. Assessment of the Cost-effectiveness of Australia's Risk-sharing Agreement for Direct-acting Antiviral Treatments for Hepatitis C: A Modelling Study. Elsevier, 2022.
MLA (9th ed.) CitationDr Nick Scott, et al. Assessment of the Cost-effectiveness of Australia's Risk-sharing Agreement for Direct-acting Antiviral Treatments for Hepatitis C: A Modelling Study. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.